The haemophilia treatment landscape is fast evolving, with many new and innovative therapies in the final stages of development or being marketed in Europe. To help our members navigate these changes, the EHC has developed a publication, the Novel Treatment Review issued twice a year with the latest therapeutic developments. The Novel Treatment Review Committee members support EHC staff in developing the content of this newsletter.

This committee is composed of:

Paul Batty
University College London, UK

Prof Jan Blatny
EHC MAG, Czechia

Prof Ana Boban
EHC MAG, Croatia

MD Panagiotis Christoforou
EHC SC Member, Greek NMO

Miguel Crato
EHC President, Portuguese NMO

Mariëtte Driessens
Dutch NMO

Radoslaw Kaczmarek
Polish NMO

Ilmar Kruis
Dutch NMO

Dr Maria Elisa Mancuso
EHC MAG, Italy

Brian O’Mahony
EHC MASAG member, Irish NMO

Prof Johannes Oldenburg
EHC MAG, Germany

David Page
Canadian Haemophilia Society

Uwe Schlenkrich

Suthesh Sivalaparatnam
Queen Mary University of London, UK

In addition to these volunteers, the EHC Novel Treatment Review is also edited by some EHC MAG and MASAG members.